Legacy Wealth Asset Management LLC Has $651,000 Stock Holdings in Haleon plc (NYSE:HLN)

Legacy Wealth Asset Management LLC trimmed its holdings in Haleon plc (NYSE:HLN) by 5.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 68,238 shares of the company’s stock after selling 4,022 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Haleon were worth $651,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of HLN. AE Wealth Management LLC lifted its holdings in Haleon by 6.1% in the 2nd quarter. AE Wealth Management LLC now owns 19,199 shares of the company’s stock worth $159,000 after purchasing an additional 1,098 shares during the last quarter. Lake Street Advisors Group LLC raised its position in shares of Haleon by 5.4% in the third quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company’s stock valued at $237,000 after purchasing an additional 1,143 shares during the period. Synovus Financial Corp raised its position in shares of Haleon by 0.8% in the third quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock valued at $1,575,000 after purchasing an additional 1,216 shares during the period. Hexagon Capital Partners LLC lifted its stake in shares of Haleon by 18.5% in the third quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company’s stock worth $84,000 after buying an additional 1,238 shares during the last quarter. Finally, Brown Brothers Harriman & Co. boosted its holdings in shares of Haleon by 21.4% during the 2nd quarter. Brown Brothers Harriman & Co. now owns 7,569 shares of the company’s stock worth $63,000 after buying an additional 1,334 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Performance

Shares of Haleon stock opened at $9.24 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The firm has a 50 day simple moving average of $9.54 and a 200 day simple moving average of $9.69. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The firm has a market cap of $41.80 billion, a P/E ratio of 27.16, a P/E/G ratio of 2.52 and a beta of 0.29.

Wall Street Analysts Forecast Growth

HLN has been the topic of a number of research analyst reports. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Finally, UBS Group raised Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.